Page 122 - Read Online

68. Ollikainen E, Tulamo R, Frösen J, Lehti S, Honkanen P, Hernesniemi J, 79. Hosaka K, Hoh BL. Inflammation and cerebral aneurysms. Transl
Niemelä M, Kovanen PT. Mast cells, neovascularization, and Stroke Res 2014;5:190‑8.
microhemorrhages are associated with saccular intracranial 80. Hasan DM, Mahaney KB, Magnotta VA, Kung DK, Lawton MT,
artery aneurysm wall remodeling. J Neuropathol Exp Neurol Hashimoto T, Winn HR, Saloner D, Martin A, Gahramanov S,
2014;73:855‑64. Dósa E, Neuwelt E, Young WL. Macrophage imaging within human
69. Hannawa KK, Eliason JL, Woodrum DT, Pearce CG, Roelofs KJ, cerebral aneurysms wall using ferumoxytol‑enhanced MRI: a pilot
Grigoryants V, Eagleton MJ, Henke PK, Wakefield TW, Myers DD, study. Arterioscler Thromb Vasc Biol 2012;32:1032‑8.
Stanley JC, Upchurch GR. L‑selectin‑mediated neutrophil 81. Spinowitz BS, Kausz AT, Baptista J, Noble SD, Sothinathan R,
recruitment in experimental rodent aneurysm formation. Circulation Bernardo MV, Brenner L, Pereira BJ. Ferumoxytol for treating iron
2005;112:241‑7. deficiency anemia in CKD. J Am Soc Nephrol 2008;19:1599‑605.
70. Marbacher S, Marjamaa J, Bradacova K, von Gunten M, 82. Lu M, Cohen MH, Rieves D, Pazdur R. FDA report: ferumoxytol
Honkanen P, Abo‑Ramadan U, Hernesniemi J, Niemelä M, Frösen J. for intravenous iron therapy in adult patients with chronic kidney
Loss of mural cells leads to wall degeneration, aneurysm growth, and disease. Am J Hematol 2010;85:315‑9.
eventual rupture in a rat aneurysm model. Stroke 2014;45:248‑54. 83. Hasan D, Chalouhi N, Jabbour P, Dumont AS, Kung DK,
71. Anidjar S, Dobrin PB, Eichorst M, Graham GP, Chejfec G. Magnotta VA, Young WL, Hashimoto T, Winn HR, Heistad D. Early
Correlation of inflammatory infiltrate with the enlargement of change in ferumoxytol‑enhanced magnetic resonance imaging signal
experimental aortic aneurysms. J Vasc Surg 1992;16:139‑47. suggests unstable human cerebral aneurysm: a pilot study. Stroke
72. Klebanoff SJ. Myeloperoxidase: friend and foe. J Leukoc Biol 2012;43:3258‑65.
2005;77:598‑625. 84. Chen JW, Pham W, Weissleder R, Bogdanov A Jr. Human
73. Nicholls SJ, Hazen SL. Myeloperoxidase and cardiovascular disease. myeloperoxidase: a potential target for molecular MR imaging in
Arterioscler Thromb Vasc Biol 2005;25:1102‑11. atherosclerosis. Magn Reson Med 2004;52:1021‑8.
74. Gounis MJ, Vedantham S, Weaver JP, Puri AS, Brooks CS, 85. Chen JW, Querol Sans M, Bogdanov A Jr, Weissleder R. Imaging of
Wakhloo AK, Bogdanov AA. Myeloperoxidase in human intracranial myeloperoxidase in mice by using novel amplifiable paramagnetic
aneurysms: preliminary evidence. Stroke 2014;45:1474‑7. substrates. Radiology 2006;240:473‑81.
75. Arbonés ML, Ord DC, Ley K, Ratech H, Maynard‑Curry C, Otten G, 86. DeLeo MJ 3rd, Gounis MJ, Hong B, Ford JC, Wakhloo AK,
Capon DJ, Teddert TF. Lymphocyte homing and leukocyte rolling Bogdanov AA Jr. Carotid artery brain aneurysm model: in vivo
and migration are impaired in L‑selectin‑deficient mice. Immunity molecular enzyme‑specific MR imaging of active inflammation in a
1994;1:247‑60. pilot study. Radiology 2009;252:696‑703.
76. Tedder TF, Steeber DA, Pizcueta P. L‑selectin‑deficient mice have
impaired leukocyte recruitment into inflammatory sites. J Exp Med
1995;181:2259‑64.
77. Vestweber D, Blanks JE. Mechanisms that regulate the function of Cite this article as: Strong MJ, Amenta PS, Dumont AS, Medel R. The
role of leukocytes in the formation and rupture of intracranial aneurysms.
the selectins and their ligands. Physiol Rev 1999;79:181‑213. Neuroimmunol Neuroinflammation 2015;2(2):107-14.
78. Zhou HF, Yan H, Cannon JL, Springer LE, Green JM, Pham CT. Source of Support: Nil. Conflict of Interest: No.
CD43‑mediated IFN‑γ production by CD8+T cells promotes
abdominal aortic aneurysm in mice. J Immunol 2013;190:5078‑85. Received: 29-08-2014; Accepted: 06-09-2014

114 Neuroimmunol Neuroinflammation | Volume 2 | Issue 2 | April 15, 2015